Methotrexate
Private Methotrexate testing in London for £189, measuring one therapeutic drug level with specialist results expected in around 2 days.
Turnaround time
2 business days
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Methotrexate Test
The Methotrexate blood test measures the concentration of Methotrexate circulating in serum, principally for therapeutic monitoring after high-dose Methotrexate treatment.
The test assesses 1 therapeutic drug-monitoring biomarker: Methotrexate.
Methotrexate is a folate-antagonist medication used in several very different clinical settings.
Low-dose Methotrexate is commonly prescribed for inflammatory disorders such as rheumatoid arthritis, psoriasis and selected autoimmune conditions.
Much higher doses are used in specialist oncology protocols.
Serum Methotrexate concentration monitoring is most established after high-dose Methotrexate chemotherapy.
Timed concentrations help clinicians determine how quickly the drug is being cleared.
This information can guide intravenous fluids, urine alkalinisation and Folinic Acid or Leucovorin rescue.
Delayed Methotrexate clearance can increase the risk of serious toxicity.
Kidney function is particularly important because Methotrexate is substantially eliminated through the kidneys.
Renal impairment can therefore cause prolonged exposure.
The timing of the blood sample relative to the Methotrexate dose is critical.
A concentration without the exact treatment and sample times can be difficult or impossible to interpret correctly.
For people taking routine low-dose weekly Methotrexate for rheumatological or dermatological disease, serum Methotrexate concentrations are not normally the principal monitoring method.
Routine safety monitoring instead focuses on Full Blood Count, liver function and kidney function.
This private test should therefore be used when a treating clinician has identified a specific reason to measure Methotrexate concentration.
What Does the Methotrexate Test Check?
The test measures circulating Methotrexate concentration. This test measures 1 specialist biomarker.
Methotrexate
Measures serum Methotrexate concentration, principally to assess clearance and toxicity risk after high-dose treatment when interpreted at a defined time after dosing.
Who May Benefit From the Methotrexate Test?
Methotrexate concentration testing is most useful within clinician-directed therapeutic monitoring.
People receiving high-dose Methotrexate chemotherapy - Timed drug levels are used to monitor clearance.
People with delayed Methotrexate elimination - Serial concentrations can determine whether exposure remains excessive.
People requiring Leucovorin rescue monitoring - Drug levels can help guide the duration and intensity of rescue treatment.
People developing kidney dysfunction during high-dose Methotrexate therapy - Reduced renal clearance can raise concentrations.
People with a previous unexpectedly high Methotrexate level - Repeat timed testing can demonstrate whether the drug is clearing.
People specifically referred by an oncology team for Methotrexate measurement - Interpretation depends on the treatment protocol.
How to Prepare
Do not change Methotrexate, Leucovorin or any oncology supportive medication based solely on a private laboratory result.
Treatment decisions require the prescribing oncology team.
Symptoms and Reasons to Consider the Methotrexate Test
Drug levels should generally be ordered according to the treatment protocol rather than symptoms alone.
Delayed Methotrexate clearance after high-dose treatment - Serial concentrations can quantify ongoing exposure.
New kidney impairment during Methotrexate treatment - Reduced clearance can substantially increase toxicity risk.
Severe mouth ulcers or mucositis after high-dose therapy - Significant toxicity requires clinical assessment.
Unexpected bone-marrow suppression - Methotrexate can impair rapidly dividing cells.
Significant liver abnormalities during treatment - Safety monitoring may require wider investigation.
A clinician-directed timed level after chemotherapy - This is the principal setting for serum Methotrexate monitoring.
Suspected Methotrexate toxicity after high-dose treatment is an urgent clinical issue.
Do not wait for routine private testing if severe mucositis, major blood-count suppression, kidney injury or other significant toxicity is suspected.
How to Book Your Methotrexate Test
The Methotrexate test can be booked privately when serum drug-level monitoring has been specifically requested.
Choose the Methotrexate
Select the individual Methotrexate blood test online.
Select your sample collection option
Arrange collection at the exact time required by the treating clinician.
Attend your appointment
A trained healthcare professional collects the blood sample and the Methotrexate dose time should be documented.
Laboratory analysis
Your serum undergoes quantitative measurement of Methotrexate.
Receive your results securely
Your authorised result is delivered securely for interpretation by the clinician managing Methotrexate therapy.
When Will I Receive My Results?
The current specialist laboratory turnaround for Methotrexate is approximately 2 days after laboratory receipt.
Timed drug levels in high-dose oncology protocols may require a more urgent hospital-based pathway.
Routine private turnaround should not be substituted for an oncology service's required monitoring schedule.
Understanding Your Results
Methotrexate results cannot be interpreted using one universal therapeutic range.
The clinically important value depends on how many hours have passed since the high-dose infusion and the treatment protocol being followed.
A concentration that is expected at an early time point can be dangerously high at a later time point.
Persistently increased concentrations suggest delayed clearance.
Kidney impairment, drug interactions and other factors can contribute.
Serial measurements may be required until the concentration falls to a sufficiently low level.
For routine low-dose weekly Methotrexate, blood concentrations are generally not used to decide whether treatment is safe or effective.
Full Blood Count, liver enzymes and kidney function are more relevant routine monitoring tests.
Why Book With London Blood Tests?
London Blood Tests provides private Methotrexate concentration testing where therapeutic drug monitoring is specifically required.
Measures Methotrexate concentration directly - The assay provides quantitative drug-level information.
Useful after high-dose treatment - Timed levels can demonstrate whether Methotrexate is clearing normally.
Relevant to toxicity monitoring - Prolonged exposure increases the risk of serious adverse effects.
Can be interpreted with kidney function - Renal clearance is central to Methotrexate elimination.
Useful alongside serial measurements - Treatment protocols can require repeated levels.
Clinician-directed testing - Exact dose and sample timing are incorporated into interpretation.
Specialist laboratory analysis - Results are expected approximately 2 days after laboratory receipt.
Clear pricing - The Methotrexate test costs £189.
Private Methotrexate Blood Test in London
London Blood Tests provides private Methotrexate concentration testing for clinician-directed therapeutic drug monitoring.
The test costs £189 and measures 1 specialist medication biomarker.
Results are expected approximately 2 days after laboratory receipt.
The test is principally relevant to timed high-dose Methotrexate monitoring rather than routine low-dose rheumatology safety checks.